NeuroBo Pharmaceuticals shares are trading higher after the company submitted an IND application to the FDA for a Phase 1 trial of DA-1726 for treatment of obesity.

NEUROBO PHARMACEUTICALS INC -3.68% Pre

NEUROBO PHARMACEUTICALS INC

NRBO

3.40

3.40

-3.68%

0.00% Pre

NeuroBo Pharmaceuticals shares are trading higher after the company submitted an IND application to the FDA for a Phase 1 trial of DA-1726 for treatment of obesity.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via